Wellcana Group has ambitious plans for 2020: The company is expanding its medical cannabis operations and its offerings to include a cannabidiol (CBD) line.
The company holds the exclusive license from Louisiana State University to grow and manufacture medical cannabis products. Wellcana currently sells medical tinctures for about 5,000 patients and is planning to launch additional medical cannabis products.
“We’ll roll out topicals first and then the strips, and then the edible chews. Then the metered dose inhalers,” Wellcana CEO John Davis told The Advocate. Wellcana then plans to roll out the same products, excluding metered inhalers, with CBD.
The Baton Rouge, Louisiana-based company plans to expand its current facility. Wellcana is concurrently seeking additional space to build a 100,000-square-foot indoor medical cannabis greenhouse and storage facility, which will also be equipped for industrial hemp processing. Wellcana is seeking area farmers who can supply hemp.
The U.S. Department of Agriculture approved Louisiana’s industrial hemp plan Dec. 23, and the state began accepting license applications Dec. 27.
